Guardian Pharmacy Services, Inc.
GRDN
$20.65
-$0.27-1.29%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -411.50% | -491.61% | -496.61% | -83.20% | 52.89% |
Total Depreciation and Amortization | -16.80% | -18.30% | -18.57% | -18.73% | 9.30% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 1,980.04% | 999.25% | 250.49% | 48.02% | -81.41% |
Change in Net Operating Assets | -475.00% | -332.42% | -112.75% | 112.91% | 142.26% |
Cash from Operations | -39.08% | -59.29% | -68.34% | -38.53% | 12.09% |
Capital Expenditure | -6.33% | 8.49% | 28.75% | 34.81% | 17.56% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -353.50% | -353.50% | -11.60% | 50.82% | 50.82% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -68.94% | -76.95% | 203.77% | 721.53% | 143.37% |
Cash from Investing | -43.59% | -28.73% | 32.78% | 47.98% | 28.50% |
Total Debt Issued | -70.90% | -49.42% | -23.60% | -26.53% | -3.47% |
Total Debt Repaid | 51.88% | 34.54% | 26.35% | 29.83% | 7.87% |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | 68.75% | 49.41% | 4.32% | 10.98% | -99.42% |
Other Financing Activities | -302.46% | -324.70% | -393.17% | 8.08% | -49.63% |
Cash from Financing | 87.71% | 84.31% | 153.47% | 32.75% | -33.51% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 3,230.90% | 1,654.48% | 16,288.84% | -206.68% | -176.39% |